Shanghai RAAS Blood Products Co., Ltd.
SHZ: 002252.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jun Xu
- Employees
- 3,350
- Headquarters
- Shanghai, China
- IPO year
- 2008
- Market cap
- CN¥37.7B
- Website
- https://www.raas-corp.com
Loading 002252…
Loading profile data…Frequently asked questions about 002252
What does Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) do?
Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanu...
Where does 002252.SZ trade?
Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002252.SZ in?
Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Shanghai RAAS Blood Products Co., Ltd.?
Jun Xu is the chief executive officer of Shanghai RAAS Blood Products Co., Ltd. (002252.SZ).
Where is Shanghai RAAS Blood Products Co., Ltd. headquartered?
Shanghai RAAS Blood Products Co., Ltd. is headquartered in China.
Does 002252.SZ pay a dividend?
Yes — Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) paid a trailing twelve-month dividend of CNY 0.05 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002252.SZ go public?
Shanghai RAAS Blood Products Co., Ltd. (002252.SZ) completed its initial public offering in 2008.